Skip to Main Content
Welcome to the Scientist.com Marketplace

Go to Main Navigation
Nov 12, 2013

This is Part 3 in a three-part series on key factors in CRO selection. (Check out Part 1 and Part 2). Use of CROs in research and drug development...

Nov 7, 2013

This is Part 2 in a three-part series on key factors in CRO selection. (Check out Part 1 and Part 3). Contract research organizations (CROs) often...

Nov 5, 2013

Successful life science startup entrepreneurs share the basics on starting a business. Aspiring entrepreneurs received advice from an optimistic...

Nov 1, 2013

Cell culture is the foundation of high throughput screening during drug development. However, it is well known that there is a big and precarious...

Oct 29, 2013

Kevin Lustig was invited by The Empowered Patient Radio Show after they heard Kevin at the Tech Coast Angels quick pitch competition. Kevin...

Oct 24, 2013

This is Part 1 in a three-part series on key factors in CRO selection. (Check out Part 2 and Part 3). Alternative strategies for approaching drug...

Oct 22, 2013

The next time your research takes you outside your field of expertise, you might consider looking for a core lab to help move your project forward...

Oct 10, 2013

Core labs are important assets to academic institutions. They are concentrated pockets of experts, to whom scientists can outsource specific parts...

Oct 8, 2013

This is Part 3 in a three-part series on patient-centered outcomes. (Check out Part 1 and Part 2). Patient perspective (patient-centered outcomes...

Oct 3, 2013

Modern medicine has made incredible advances with treatments that have changed the prospects for many diseases. The healthcare and pharmaceutical...